We Help You Understand Treatment Decisions.
And Connect You, at Your Request.
CancerCareE is not a hospital, not a medical provider, and not a medical tourism company. We are an independent platform that helps patients understand how treatment decisions are made, and—only at their explicit request—forwards their name and contact information to partner centers.
- $0 patient fees — always. We never charge patients.
- Independent information on treatment options and decision pathways
- At your request, we introduce you to one or more partner centers
- All medical decisions are made by licensed physicians at partner institutions
- Dedicated Physician Referral Portal for licensed oncologists
Request Introduction
If you would like to be connected with one or more partner centers, please complete this form. We will forward only your name and contact information. No medical data is collected.
Platform Transparency
Data from our partner network. Updated regularly. No marketing claims — just facts.
Who We Serve
Whether you're a patient, a family member, or a referring physician — we provide information and connection pathways.
For Patients & Families
- Independent information about treatment decision pathways
- Connection to partner centers at your explicit request
- Transparent cost information
- Multi-language support
For Advanced Cancer Cases
- Information on options when standard treatments have been exhausted
- Introduction to centers offering CAR-T, TIL, NK, Gamma Delta therapies
- Clinical trial matching information across countries
For Referring Physicians
- Secure physician-to-physician portal
- Peer case review by specialist oncologists at partner centers
- Clinical trial matching information
- Anonymized outcome data
Partner Centers Across 8 Countries
Public hospitals, private centers, and clinical trial sites in our partner network.
China
World leader in CAR-T research. 700+ active trials. Public & private hospitals.
PRIMARY NETWORKSouth Korea
Advanced immunotherapy centers. Samsung, Asan, Seoul National University.
Singapore
Premium oncology hub. National Cancer Centre, Mount Elizabeth, Parkway.
India
Cost-effective advanced care. Tata, Apollo, AIIMS, Rajiv Gandhi Cancer.
Turkey
JCI-accredited hospitals. Arabic & English support. Strategic location.
Germany
European oncology excellence. Charité, Heidelberg, LMU Munich.
USA
FDA-approved therapies. MD Anderson, Memorial Sloan Kettering, Mayo Clinic.
Therapy Intelligence
Evidence-based information on advanced cellular and immunotherapy treatments.
CAR-T Cell Therapy
Genetically modified T-cells targeting specific cancer antigens (CD19, BCMA, CD22).
Source: ClinicalTrials.gov ↗
Gamma Delta T-Cell Therapy
Innate immune cells effective against solid tumors without requiring HLA matching.
Source: PubMed ↗
TIL Therapy
Tumor-Infiltrating Lymphocytes expanded from the patient's own tumor.
Source: PubMed ↗
NK Cell Therapy
Natural Killer cells providing innate immunity against cancer cells, with lower risk of CRS.
Source: PubMed ↗
Is Advanced Cellular Therapy an Option to Explore?
An honest assessment framework based on clinical evidence. This is information, not medical advice.
May Be Appropriate If
- Relapsed after 2+ standard treatments
- Specific cancer type (B-ALL, DLBCL, Myeloma)
- Adequate organ function (liver, kidney, heart)
- No active uncontrolled infection
- Performance status ECOG 0-2
May Not Be Suitable If
- Early-stage cancer (standard treatment works)
- Severe organ dysfunction
- Active autoimmune disease (relative)
- Performance status ECOG 3-4
- Untreated active infection
Requires Expert Review If
- Solid tumors (trial-dependent)
- Elderly patients (case-by-case)
- Prior CAR-T failure
- Rare cancer types
- Complex medical history
This is an informational guide, not medical advice. Final eligibility is determined by licensed physicians at partner centers.
The Truth About CAR-T in China
No marketing claims. Just facts — the good, the challenging, and what we won't promise.
What's Real & Verified
- 700+ active CAR-T clinical trials (ClinicalTrials.gov verified)
- $30K-$80K cost range (documented from partner hospitals)
- JCI-accredited partner hospitals in major cities
- Published remission data from peer-reviewed studies
- Legal right for international patients to seek treatment
What's Challenging
- Language barriers (translation support available)
- Regulatory differences vs. your home country
- Follow-up care logistics after returning home
- Not all trials accept international patients
- Travel and accommodation costs are additional
What We Won't Promise
- Guaranteed treatment outcomes or cures
- Same-day approvals or instant access
- Treatment for every case
- Replacement for your local physician's care
- Hidden fees disguised as "coordination costs"
Compare Treatment Options
Evidence-based comparisons to help you understand your options.
CAR-T vs Chemotherapy
Compare efficacy, side effects, and costs between cellular therapy and traditional chemotherapy.
Read comparisonTIL vs Immunotherapy
Tumor-infiltrating lymphocytes compared with immune checkpoint inhibitors.
Read comparisonNK Cells vs CAR-T
Natural killer cells or modified T-cells: understanding the differences.
Read comparisonChina vs USA in Cellular Therapy
Comprehensive comparison: cost, wait times, clinical trials, and quality of care.
Read comparisonData & Insights
Facts and figures based on the latest studies and partner network data.
CAR-T Cost by Country
China: $30-80K | USA: $375-500K | India: $40-90K
Treatment Wait Time
China: 2-4 weeks | USA & Europe: 4-8 weeks
Active Clinical Trials
China leads the world in CAR-T and immunotherapy trials
Evidence Overview
Reported survival improvement with cellular therapy vs chemotherapy in eligible patients per clinical studies
How Introduction Works
A clear, transparent process from your request to direct connection with a partner center.
You Submit an Introduction Request
Complete the form with your name, contact information, country of residence, and preferred destination. No medical data is collected.
We Forward Your Contact Information
With your explicit consent, we forward your name and contact details to one or more partner centers in your preferred destination country.
Partner Center Contacts You Directly
The partner treatment center or medical tourism company contacts you directly. From this point, all communication is between you and them.
Medical Assessment by Licensed Physicians
The center's physicians review your medical records, make diagnoses, and discuss treatment options directly with you.
Treatment & Follow-up
All treatment decisions, logistics, and follow-up care are managed directly between you and the partner center. CancerCareE's role ends at introduction.
Why Patients Use Our Platform
Independent information and transparent introduction — always at no cost to patients.
Fully Transparent Process
Clear communication at every step. No hidden fees. No surprises. Ever.
Global Partner Network
Partner institutions across 8 countries including China, India, S. Korea, Turkey, USA, Germany, and Singapore.
Multi-Language Support
Platform available in English, Arabic, Turkish, Russian, Persian, Chinese, and Korean.
Advanced Therapy Information
We focus on providing information about advanced cancer therapies — CAR-T, TIL, NK, Gamma Delta.
Clear & Transparent Role
We are an independent information and introduction platform. We never replace your physician's judgment.
$0 Patient Fees
We never charge patients. After introduction, we may receive a fixed referral fee from partner companies. Learn more.
For Referring Physicians
A dedicated portal for licensed oncologists who want to expand treatment options for their patients.
Physician Referral Portal
Secure platform for referring patients to partner centers. Direct physician-to-physician communication.
Access PortalPeer Case Review
Request peer review of complex cases by specialist oncologists at partner centers.
Request ReviewOutcome Data Sharing
Access anonymized outcome data from partner centers to inform clinical decisions.
View DataAvailable to licensed oncologists and hematologists only.
Specialists at Partner Centers
These physicians practice independently at partner hospitals. CancerCareE does not employ any physicians and has no role in their medical judgment.
Dr. Brian Liu, MD, PhD
Specialist in CAR-T cell therapy for hematologic malignancies and gene therapy approaches in China.
Dr. Liu practices independently at a partner hospital. CancerCareE does not employ physicians and has no role in their medical judgment.
View Full Profile
Dr. Qian Li, MD
Expert in CAR-T therapy for refractory blood disorders and stem cell transplantation in China.
Dr. Li practices independently at a partner hospital. CancerCareE does not employ physicians and has no role in their medical judgment.
View Full Profile
Dr. Yafei Wang, MD
Leading specialist in multiple myeloma, lymphoma, leukemia, and advanced transplant techniques.
Dr. Wang practices independently at a partner hospital. CancerCareE does not employ physicians and has no role in their medical judgment.
View Full ProfilePatient Introduction Reports
Examples of patients who were introduced to partner centers through our platform. No medical outcome claims are made.
Medical Library
Educational content about advanced cancer treatments.
What After Standard Treatment Options?
Understanding pathways for patients who have exhausted conventional options.
Read Article
Treatment Access Guides: Asia and Europe
Practical information for international patients.
Read ArticleFrequently Asked Questions
Common questions about our platform.
CancerCareE is an independent content and patient introduction platform — not a healthcare provider, hospital, or medical practice. We help patients understand treatment decisions and, at their explicit request, forward their name and contact information to one or more partner centers across 8 countries.
Patient introduction services are provided at absolutely no cost to patients. After introduction, we may receive a fixed referral fee from partner companies. Learn more about our financial model.
No. CancerCareE is registered as a digital health content and marketing company. We are not a medical tourism company, facilitator, or healthcare provider. We provide information and introduction services only.
No ethical organization can guarantee medical outcomes. We provide transparent, evidence-based information and, at your request, introduce you to partner centers. All medical decisions are made by licensed physicians at those centers.
We can introduce patients to multiple partner institutions across 8 countries including China, India, South Korea, Turkey, USA, Germany, and Singapore. We always aim to provide at least two options per destination country.
Physicians at partner centers make all medical decisions. We also have a dedicated Physician Referral Portal for licensed oncologists who wish to refer patients for peer review or clinical trial matching.
For Hospitals, Physicians & Medical Partners
Are you an oncology center or medical professional interested in joining our partner network?
Explore Partnership Opportunities